BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
gujarat inject (kerala) ltd. stock

GUJARAT INJECT (KERALA) LTD. Share Price

20.92 0.98 (4.91%)
Dec 11 2024 01:19 PM Pharmaceuticals NSE: GUJINJEC

GUJARAT INJECT (KERALA) LTD. Share Price Update

As of the latest trading session, GUJARAT INJECT (KERALA) LTD. share price is currently at 20.92, which is up by 0.98 from its previous closing. Today, the stock has fluctuated between 20.92 and 20.92. Over the past year, GUJARAT INJECT (KERALA) LTD. has achieved a return of 54.24 %. In the last month alone, the return has been -5.16 %. Read More...

GUJARAT INJECT (KERALA) LTD. Performance

Day Range

Low20.92 High20.92
17.63

52 Week Range

Low 8.35 High 19.93
17.63

GUJARAT INJECT (KERALA) LTD. Share Price

524238

GUJINJEC

img img img img
No Data Available

Open Price

20.92

Prev. Close

19.93

Volume (Shares)

6395.00

Total traded value

1.24

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

GUJARAT INJECT (KERALA) LTD. Fundamentals


(Standalone)

Market Cap (Cr) 25.80
PE Ratio (TTM) 33.26
Book Value / Share 6.65
Beta 0.50
ROE 0.62%
EPS (TTM) 0.53
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.61

GUJARAT INJECT (KERALA) LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 8.61
Operating Expense 8.07
Net Profit 0.61
Net Profit Margin (%) 7.08
Earnings Per Share (EPS) 0.42
EBITDA 0.71
Effective Tax Rate (%) 14.08
Particulars JUN 2024 (Values in Cr)
Revenue 3.05
Operating Expense 2.88
Net Profit 0.12
Net Profit Margin (%) 3.93
Earnings Per Share (EPS) 0.08
EBITDA 0.17
Effective Tax Rate (%) 23.52
Particulars MAR 2024 (Values in Cr)
Revenue 5.42
Operating Expense 5.37
Net Profit 0.04
Net Profit Margin (%) 0.73
Earnings Per Share (EPS) 0.03
EBITDA 0.05
Effective Tax Rate (%) 20.00
Particulars DEC 2023 (Values in Cr)
Revenue 0.22
Operating Expense 0.25
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.01
EBITDA 0.01
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.01
Net Profit 0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.03
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 5.79
Operating Expense 5.74
Net Profit 0.08
Net Profit Margin (%) 1.38
Earnings Per Share (EPS) 0.07
EBITDA 0.11
Effective Tax Rate (%) 18.18
Particulars MAR 2023 (Values in Cr)
Revenue 0.17
Operating Expense 0.55
Net Profit 0.04
Net Profit Margin (%) 23.52
Earnings Per Share (EPS) 0.08
EBITDA 0.06
Effective Tax Rate (%) 16.66
Particulars MAR 2022 (Values in Cr)
Revenue 0.02
Operating Expense 0.07
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.01
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.01
Operating Expense 0.12
Net Profit -0.11
Net Profit Margin (%) -1100.00
Earnings Per Share (EPS) -0.22
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 0.01
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 5.01
ROE % 0.62
ROCE % 0.76
Total Debt to Total Equity 0.08
EBITDA Margin 1.90
Particulars MAR 2023 (Values in Cr)
Book Value / Share -1.71
ROE % 1.08
ROCE % 1.14
Total Debt to Total Equity 0.00
EBITDA Margin 35.29
Particulars MAR 2022 (Values in Cr)
Book Value / Share -1.80
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -1.80
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -1100.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share -1.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.91
Total Assets 8.68
Total Liabilities 8.68
Total Equity 8.54
Share Outstanding 11306500
Price to Book Ratio 1.99
Return on Assets (%) 0.95
Return on Capital (%) 0.97
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 0.30
Total Liabilities 0.30
Total Equity -0.83
Share Outstanding 4899000
Price to Book Ratio -4.58
Return on Assets (%) 13.53
Return on Capital (%) -17.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.06
Total Liabilities 0.06
Total Equity -0.87
Share Outstanding 4899000
Price to Book Ratio 0.00
Return on Assets (%) 3.41
Return on Capital (%) -1.53
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.01
Total Liabilities 0.01
Total Equity -0.88
Share Outstanding 4899000
Price to Book Ratio 0.00
Return on Assets (%) -599.51
Return on Capital (%) 55.72
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 0.01
Total Liabilities 0.01
Total Equity -0.77
Share Outstanding 4899000
Price to Book Ratio 0.00
Return on Assets (%) 1.55
Return on Capital (%) -0.12
Particulars MAR 2024 (Values in Cr)
Net Income 0.10
Cash from Operations -6.00
Cash from Investing 0.00
Cash from Financing 8.88
Net change in Cash 2.85
Free Cash Flow -6.00
Particulars MAR 2023 (Values in Cr)
Net Income 0.05
Cash from Operations 0.06
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.05
Free Cash Flow 0.06
Particulars MAR 2022 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2021 (Values in Cr)
Net Income -0.10
Cash from Operations -0.10
Cash from Investing 0.00
Cash from Financing 0.10
Net change in Cash 0.00
Free Cash Flow -0.10
Particulars MAR 2020 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 56.52 85.64 10.74 433.13 35.27 / 77.70
AMRUTAJAN HEALTH LTD 744.45 50.54 7.46 2152.25 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 7478.00 142.71 26.25 18695.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 123.50 16.08 1.26 1300.48 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 18.10
  • 26 Days 16.60
  • 10 Days 17.70
  • 50 Days 14.90
  • 12 Days 17.40
  • 100 Days 13.70
  • 20 Days 16.70
  • 200 Days 8.10
18.24
PIVOT
First Resistance 18.86
Second Resistance 20.08
Third Resistance 20.70
First Support 17.02
Second Support 16.40
Third Support 15.18
RSI 72.55
MACD 0.71
Commodity Channel Index (CCI) 77.07
ADX 16.00
Williams % R -33.64

Over 1 Month

down

-5.16

Over 3 Months

down

23.28

Over 6 Months

down

10.25

Over 1 Year

down

54.24

Over 3 Years

down

93.58

Over 5 Years

down

0.00

GUJARAT INJECT (KERALA) LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

GUJARAT INJECT (KERALA) LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
100.0
Promoter Holdings
0.0
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Shivlal Kuberbhai Patel Public Shareholding 1750000.0 11.95
Jignesh Shivlal Makasana Public Shareholding 1750000.0 11.95
Rajesh Shantilal Sanghvi Public Shareholding 1000000.0 6.83
Jagrutbhai Kesaribhai Mehta Public Shareholding 1000000.0 6.83
Bhupendra J Rathod (huf) Public Shareholding 600000.0 4.1
Jagatsing Nathusingh Rathod Public Shareholding 600000.0 4.1
Jaydeepa Bhupendra Rathod Public Shareholding 600000.0 4.1
Kamlaba J Rathod Public Shareholding 542500.0 3.7
Meenaben Surendrakumar Shah Public Shareholding 500000.0 3.41
Shah Surendra Nemchand Public Shareholding 500000.0 3.41
Pradip Narottambhai Vegada (huf) Public Shareholding 432500.0 2.95
Patel Mital Shreyasbhai Public Shareholding 250000.0 1.71
Gautam Keshavlal Chauhan (huf) Public Shareholding 225000.0 1.54
Parikshit Mahatma Public Shareholding 161989.0 1.11

GUJARAT INJECT (KERALA) LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About GUJARAT INJECT (KERALA) LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by GUJARAT INJECT (KERALA) LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Gujarat Inject (Kerala) Ltd?

Answer Field

The share price of Gujarat Inject (Kerala) Ltd for NSE is ₹ 0.00 and for BSE is ₹ 17.63.

What is the Market Cap of Gujarat Inject (Kerala) Ltd?

Answer Field

The market cap of Gujarat Inject (Kerala) Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 25.80 Cr. as of now.

What is the 52 Week High and Low of Gujarat Inject (Kerala) Ltd?

Answer Field

The 52 Week High and Low of Gujarat Inject (Kerala) Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 19.47 and ₹ 7.60.

How to Buy Gujarat Inject (Kerala) Ltd share?

Answer Field

You can trade in Gujarat Inject (Kerala) Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Gujarat Inject (Kerala) Ltd?

Answer Field

The 1 year returns on the stock has been 54.24%.

What is the Current Share Price of Gujarat Inject (Kerala) Ltd?

Answer Field

Gujarat Inject (Kerala) Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 17.63 as on Dec 11 2024 01:19 PM.

What is the Market Cap of Gujarat Inject (Kerala) Ltd Share?

Answer Field

The market cap of Gujarat Inject (Kerala) Ltd for NSE ₹ 0.0 & for BSE ₹ 25.80 as on Dec 11 2024 01:19 PM.

What is the P/E Ratio of Gujarat Inject (Kerala) Ltd Share?

Answer Field

As on Dec 11 2024 01:19 PM the price-to-earnings (PE) ratio for Gujarat Inject (Kerala) Ltd share is 33.26.

What is the PB ratio of Gujarat Inject (Kerala) Ltd Share?

Answer Field

As on Dec 11 2024 01:19 PM, the price-to-book (PB) ratio for Gujarat Inject (Kerala) Ltd share is 6.65.

How to Buy Gujarat Inject (Kerala) Ltd Share?

Answer Field

You can trade in Gujarat Inject (Kerala) Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gujarat Inject (Kerala) Ltd Share on Bajaj Broking App?

Answer Field

To buy Gujarat Inject (Kerala) Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gujarat Inject (Kerala) Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader